PT - JOURNAL ARTICLE AU - Harry J. Davies AU - Ian Williams AU - Nicholas S. Peters AU - Danilo P. Mandic TI - In-Ear SpO2: A Tool for Wearable, Unobtrusive Monitoring of Hypoxaemia in COVID-19 AID - 10.1101/2020.06.08.20124883 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.08.20124883 4099 - http://medrxiv.org/content/early/2020/06/09/2020.06.08.20124883.short 4100 - http://medrxiv.org/content/early/2020/06/09/2020.06.08.20124883.full AB - Non-invasive ambulatory estimation of blood oxygen saturation has emerged as an important clinical requirement to detect hypoxemia in the delayed post-infective phase of COVID-19, where dangerous hypoxia may occur in the absence of subjective breathlessness. This immediate clinical driver, combined with the general quest for more personalised health data, means that pulse oximetry measurement of capillary oxygen saturation (SpO2) will likely expand into both the clinical and consumer market of wearable health technology in the near future. In this study, we set out to establish the feasibility of SpO2 measurement from the ear canal as a convenient site for long term monitoring, and perform a comprehensive comparison with the right index finger - the conventional clinical measurement site. During resting blood oxygen saturation estimation, we found a root mean square difference of 1.47% between the two measurement sites, with a mean difference of 0.23% higher SpO2 in the right ear canal. Through the simultaneous recording of pulse oximetry from both the right ear canal and index finger during breath holds, we observe a substantial improvement in response time between the ear and finger that has a mean of 12.4 seconds and a range of 4.2 - 24.2 seconds across all subjects. Factors which influence this response time, termed SpO2 delay, such as the sex of a subject are also explored. Furthermore, we examine the potential downsides of ear canal blood oxygen saturation measurement, namely the lower photoplethysmogram amplitude, and suggest ways to mitigate this disadvantage. These results are presented in conjunction with previously discovered benefits such as robustness to temperature, making the case for measurement of SpO2 from the ear canal being both convenient and superior to conventional finger measurement sites for continuous nonintrusive long term monitoring in both clinical and everyday-life settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Racing Foundation grant 285/2018, MURI/EPSRC grant EP/P008461, the Dementia Research Institute at Imperial College London, the BHF Centre of Research Excellence, the Imperial Centre for Cardiac Engineering, the Imperial Health Charity and the NIHR Biomedical Research Centre.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ministry of Defence Research Ethics Committee: 881/MODREC/18All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data is unavailable given GDPR.